期刊文献+

糖尿病视网膜病变玻璃体切割术中应用曲安奈德的双重效果 被引量:5

Twin Effects of Using Triamcinolone Acetonide in the Vitrectomy Surgery of Diabetic Retinopathy
下载PDF
导出
摘要 目的评价增殖性糖尿病视网膜病变(PDR)玻璃体切割手术(PPV)中应用曲安奈德(TA)对于术中清除残留玻璃体、术后抗炎的效果。方法回顾性分析本院2006年12月~2008年12月因增殖性糖尿病视网膜病变住院接受玻璃体切割术治疗患者27例29眼,术中常规PPV后辅以TA标记,观察其清除残留玻璃体皮质的作用,比较手术前后视力、眼压,观察术后眼内炎症反应及并发症。结果由于应用了TA,术中玻璃体后皮质清除较为干净,术后前房炎症反应较轻、并发症少,术后视力有明显改善。尽管术后眼压升高,但可经药物控制。结论玻璃体切割术治疗增殖性糖尿病视网膜病变辅以TA治疗,不仅有利于术中清除残留玻璃体,而且有利于提高术后视力、减少术后炎症反应及并发症的发生。 Objective To evaluate the removal residual vitreous and postoperative anti-inflammatory effect of applicating triamcinolone acetonide(TA) in surgery of pars plana vitrectomy(PPV) for proliferative diabetic retinopathy(PDR). Methods 27 cases of 29 eyes of proliferative diabetic retinopathy treated by vitrectomy in our hospital from December 2006 to December 2008 were retrospectively analyzed.Marked with TA after conventional vitrectomy,the effect of removing the residual vitreous cortex was observed,and the visual acuity and intraocular pressure before and after surgery was compared,post-operation intraocular inflammatory and other complications was also observed. Results As the result of applicating TA,the removal of posterior vitreous cortex is much clean.Less postoperative anterior chamber inflammation,fewer complications and a significant improvement in visual acuity was achieved.Although there was the postoperative intraocular pressure,it can be controlled by drugs. Conclusion The proliferative diabetic retinopathy vitrectomy assisted by TA is not only conductive to the removal of residual vitreous surgery,but will also help to improve the postoperative visual acuity,reducing postoperative inflammatory response and complications.
出处 《南华大学学报(医学版)》 2010年第1期77-79,共3页 Journal of Nanhua University(Medical Edition)
基金 省卫生厅课题(C2008-011) 省科技计划项目(2009FJ3033) 诺美国际基金资助
关键词 曲安奈德 增殖性糖尿病视网膜病变 玻璃体切割术 triamcinolone acetonide proliferative diabetic retinopathy vitrectomy
  • 相关文献

参考文献7

  • 1Peyman GA,Cheema R,Conway MD,et al.Triamcinolone acetonide as an aid to visualization of the vitreous and the posterior hyaloid during pars plana vitrectomy[J].Retina,2000,20(5):554-555.
  • 2Cheema RA,Peyman GA,Fang T,et al.Triamcinolone acetonide as an adjuvant in the surgical treatment of retinal detachment with proliferative vitreoretinopathy[J].Ophthalmic Surg Lasers Imaging,2007,38(5):365-370.
  • 3Stitt AW,Moore JE,Sharkey JA,et al.Advanced glycation end products in vitreous:structural and functional implications for diabetic vitreopathy[J].Invest Ophthalmol Vis Sci,1998,39(13):2517-2523.
  • 4Matsumoto H,Yamanaka I,Hisatomi T,et al.Triamcinolone acetonide-assisted pars plana vitrectomy improves residual posterior vitreous hyaloid removal:ultrastructural analysis of the inner limiting membrane[J].Retina,2007,27(2):174-179.
  • 5Sakamoto T,Miyazaki M,Hisatomi T,et al.Triamcinolone-assisted pars plana vitrectomy improves the surgical procedures and decreases the postoperative blood-ocular barrier breakdown[J].Graefes Arch Clin Exp Ophthalmol,2002,240(6):423-429.
  • 6Conway MD,Canakis C,Livir-Rallatos C,et al.Intravitreal triamcinolone acetonide for refractory chronic pseudophakic cystoid macular edema[J].J Cataract Refract Surg,2003,29(1):27-33.
  • 7张静琳,叶荣花,吕林,李永浩.曲安奈德璃体腔内注射在糖尿病视网膜病变手术中的运用[J].中华眼底病杂志,2005,21(4):244-244. 被引量:14

二级参考文献2

共引文献13

同被引文献50

  • 1武志峰,董凌峰,张亦农,吴又凯,曹建琴,张清.广角观察系统在外伤性玻璃体手术中的应用[J].眼外伤职业眼病杂志,2005,27(11):853-854. 被引量:10
  • 2杜磊,邢怡桥,陈长征.曲安奈德辅助显示玻璃体切割术中残留的玻璃体后皮质[J].中国实用眼科杂志,2006,24(7):719-721. 被引量:7
  • 3鲍炯琳,臧晶,朱宇东,林文雄.增殖性糖尿病视网膜病变的玻璃体切除术的疗效观察[J].中国眼耳鼻喉科杂志,2007,7(2):94-95. 被引量:11
  • 4滕毓明,孙丽珍,吕静.玻璃体切割术治疗增生性糖尿病性视网膜病变疗效观察[J].临床眼科杂志,2007,15(3):255-256. 被引量:7
  • 5Jorge R, Costa RA, Calucci D, et al. Intravitreal bevacizumab (Avastin) for persistent new vessels in diabetic retinopathy (IBEPE study) [J].Retinas, 2006,26(9) : 999-1005.
  • 6Hood PP, Cotter TP, Costello JF, et al. Effect of intravenous cor- ticosteroid on ex vivo leukotriene generation by blood leuco- cytes of normal and asthmatic patients [J].Thorax, 1999, 54: 1075-1082.
  • 7Avery RL, Pearlman J, Pieramici DJ, et al. Intravitreal bevaci- zumab(Avastin)in the treatment of proliferative diabetic retinop- athy[J]. Ophthalmology,2006,113 : 1695-1705.
  • 8Ozaki NK, Beharry KD, Nishihara KC, et al.Regulation of retinal vascular endothelial growth factor and receptors in rabbits ex- posed to hyperoxia[J]. Invest Ophthalmol Vis Sci, 2002,43: 1546-1557.
  • 9Wilson CA,Berkowitz BA,Sato Y,et al.Treatment with intravitre- al steroid reduces blood-retinal barrier breakdown due to reti- nal photocoagulation[J]. Arch Ophthalmol, 1992,10:1155-1159.
  • 10Presta LG,Chen H,O'Connor SJ,et al. Humanization of an an- ti-vascular endothelial growth factor monoclonal antibody for the therapy of soild tumors and other disorders[J].Cancer Res, 1997,57 (20) :4593-4599.

引证文献5

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部